Stockscreener 앱 받기
297.50
3.02%
8.71
시간 외 거래:
297.50
전일 마감가:
$288.79
열려 있는:
$285.04
하루 거래량:
429.81K
Relative Volume:
0.86
시가총액:
$8.29B
수익:
$7.46M
순이익/손실:
$-303.27M
주가수익비율:
-22.09
EPS:
-13.4668
순현금흐름:
$-249.12M
1주 성능:
-1.93%
1개월 성능:
-10.29%
6개월 성능:
+604.64%
1년 성능:
+670.33%
1일 변동 폭
$285.00
$302.46
1주일 범위
$285.00
$316.06
52주 변동 폭
$26.70
$356.00
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
명칭
Praxis Precision Medicines Inc
전화
617-300-8460
주소
99 HIGH STREET, 30TH FLOOR, BOSTON
Compare PRAX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRAX
Praxis Precision Medicines Inc
|
297.50 | 8.04B | 7.46M | -303.27M | -249.12M | -13.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-24 | 개시 | Wolfe Research | Outperform |
| 2026-02-02 | 개시 | Wells Fargo | Equal Weight |
| 2025-12-15 | 재확인 | Oppenheimer | Outperform |
| 2025-11-19 | 개시 | BTIG Research | Buy |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-07 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-03 | 재확인 | H.C. Wainwright | Buy |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-08-05 | 개시 | Oppenheimer | Outperform |
| 2024-06-24 | 개시 | Needham | Buy |
| 2024-06-18 | 개시 | Guggenheim | Buy |
| 2024-05-01 | 개시 | Robert W. Baird | Outperform |
| 2023-09-19 | 개시 | Truist | Buy |
| 2022-06-06 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-12-16 | 개시 | H.C. Wainwright | Buy |
| 2021-08-26 | 개시 | BofA Securities | Buy |
| 2021-04-26 | 개시 | William Blair | Outperform |
| 2020-11-11 | 개시 | Wedbush | Outperform |
| 2020-11-10 | 개시 | Cowen | Outperform |
| 2020-11-10 | 개시 | Evercore ISI | Outperform |
| 2020-11-10 | 개시 | Piper Sandler | Overweight |
모두보기
Praxis Precision Medicines Inc 주식(PRAX)의 최신 뉴스
5AM Venture Divests Entire Praxis Precision Medicines Position | February 2026 FilingNews and Statistics - IndexBox
Will Extended Cash Runway And Dual FDA Filings Shift Praxis Precision Medicines' (PRAX) Narrative Toward Commercialization? - Yahoo Finance
Praxis Precision Medicines (PRAX) reports $926M 2025 cash balance, extended runway - MSN
Praxis Precision Medicines (PRAX) Reports $926M 2025 Cash Balance, Extended Runway - Insider Monkey
PRAX PE Ratio & Valuation, Is PRAX Overvalued - Intellectia AI
Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million - AOL.com
Algert Global LLC Increases Stock Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Cormorant Sells $9.31M in Praxis Shares, Holding Remains Top Position | 2026 UpdateNews and Statistics - IndexBox
This biotech stock, which has surged by 700%, remains one of the leading holdings even after a $9.3 million sale in the previous quarter. - Bitget
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter - Yahoo Finance
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter - The Motley Fool
HighVista Strategies LLC Has $5.04 Million Stock Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings - AOL.com
Praxis Precision Medicines (PRAX) Is Down 5.4% After Major Institutional Buying and FDA FilingsHas The Bull Case Changed? - simplywall.st
Is Praxis Precision Medicines (PRAX) Still Attractive After Its Big Share Price Run? - Yahoo Finance
Praxis Precision Medicines, Inc. $PRAX Shares Sold by B Group Inc. - MarketBeat
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year - AOL.com
A Look At Praxis Precision Medicines (PRAX) Valuation After New Driehaus Investment And Recent FDA Filings - simplywall.st
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline - Yahoo Finance
Liquidity Mapping Around (PRAX) Price Events - Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY), BillionToOne, Inc. Class A (BLLN) and Praxis Precision Medicines (PRAX) - The Globe and Mail
BTIG Maintains Buy on Praxis Precision Medicines (PRAX) March 2026 - Meyka
BTIG reiterates Buy on Praxis Precision Medicines stock at $843 By Investing.com - Investing.com Canada
BTIG reiterates Buy on Praxis Precision Medicines stock at $843 - Investing.com
Vanguard Group Inc. Increases Stock Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Knott David M Jr Invests $1.48 Million in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Praxis Precision Medicines Stock Drops After Culper Research Reveals Short Position - MSN
Praxis Precision Medicines, Inc. $PRAX Shares Bought by Rafferty Asset Management LLC - MarketBeat
Praxis Precision Medicines, Inc. $PRAX Shares Sold by TD Asset Management Inc - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
A Look At Praxis Precision Medicines (PRAX) Valuation After Wider Full Year And Q4 Net Loss - simplywall.st
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biotech Praxis gives 2,931 stock units to 14 new employees - Stock Titan
PRAX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Praxis Eyes Blockbuster Future As Precision Neurology Pipeline Matures - Citeline News & Insights
Why (PRAX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
GSA Capital Partners LLP Trims Stock Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotech Powerhouse with 76% Upside Potential - DirectorsTalk Interviews
How Investors Are Reacting To Praxis (PRAX) Wider Losses, Fresh NDAs And Multi‑Year Cash Runway - simplywall.st
Praxis Precision Medicines stock hits 52-week high at 327.0 USD - Investing.com Nigeria
Praxis Precision Medicines (NASDAQ:PRAX) Raised to Strong-Buy at Wolfe Research - MarketBeat
Wolfe Research initiates coverage of Praxis Precision Medicines (PRAX) with outperform recommendation - MSN
Assessing Praxis Precision Medicines (PRAX) Valuation After Strong Recent Share Price Momentum - simplywall.st
Wolfe Research initiates Praxis stock with outperform rating - Investing.com
Wolfe Research initiates Praxis stock with outperform rating By Investing.com - Investing.com India
Wolfe Research Initiates Coverage of Praxis Precision Medicines (PRAX) with Outperform Recommendation - Nasdaq
Wolfe Research Initiates Coverage on Praxis Precision Medicine (PRAX) | PRAX Stock News - GuruFocus
A Look At Praxis Precision Medicines (PRAX) Valuation After Recent Share Price Momentum - Yahoo Finance
3,826 Shares in Praxis Precision Medicines, Inc. $PRAX Purchased by ProShare Advisors LLC - MarketBeat
Praxis NDAs And FDA Designations Put Focus On Valuation Upside - Yahoo! Finance Canada
Praxis Precision Medicines Inc (PRAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):